Tasnim is one of the fastest growing privately-owned life sciences companies in Iran. The companys first product was launched five years ago. The three years Compound Annual Growth (CAGR) from 2012-2014 is 32%. Moreover, the three years in-the-market growth of the companys brands in urology, supplements and diabetes was 42%, 113% and 45% respectively. Tasnim's current product portfolio comprises twenty-five (25) prescription and supplement brands. The company holds leadership positions in four therapeutic segments. Approximately thirty (30) new products are awaiting regulatory approval and are planned to be launched within the next two years. Tasnim's products are manufactured in two wholly-owned state-of-the-art GMP certified facilities. The company has 1300 m2 of storage capacity in a temperature- controlled warehouse for finished and active ingredients. Moreover, Tasnim engaged in intensive collaboration with international companies and embarked on aspirational target to largely expand the product portfolio in the next 4 years and steps as the major private pharmaceutical company in Iran.